Tiprinast [(3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]- pyrimidine-2-carboxylic acid] is a new antiallergy compound which shares many of the pharmacological actions of disodium cromoglycate (DSCG). Both compounds inhibit passive cutaneous anaphylaxis in the rat, histamine release from rat peritoneal mast cells and nasal constriction due to antigen in the rat. In all cases tiprinast is more potent than DSCG and also longer acting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0192-0561(85)90149-3 | DOI Listing |
Publication Analysis
Top Keywords
selected immunologic
4
immunologic properties
4
properties tiprinast
4
tiprinast non-steroidal
4
non-steroidal antiallergy
4
antiallergy agent
4
agent tiprinast
4
tiprinast [34-dihydro-5-methyl-6-2-methylpropyl-4-oxothieno[23-d]-
4
[34-dihydro-5-methyl-6-2-methylpropyl-4-oxothieno[23-d]- pyrimidine-2-carboxylic
4
pyrimidine-2-carboxylic acid]
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!